Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists

Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists

US Patent 7452862 · Granted Nov 18, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
NK-3 receptor antagonists for therapeutic or cosmetic treatment of excess body f2025
Neurotensinergic agonists and methods of using same preventing or treating pain2025
Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deu2024
Piperidine derivatives as METTL3 inhibitors2024
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin2023
Macrocyclic compounds and methods of preventing or treating pain2023
NK-3 receptor antagonists for therapeutic treatment of leptin-related disease2022
NK-3 receptor antagonists for therapeutic treatment of leptin-related disease2022
Cyclative release of peptidic compounds2022
Deuterated fezolinetant2021